U S PHYSICAL THERAPY INC /NV Proceeds from Noncontrolling Interests
U S PHYSICAL THERAPY INC /NV (USPH) reported Proceeds from Noncontrolling Interests of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromMinorityShareholders · last filed 2026-02-27
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for the quarter ending 2025-03-31 was $646.00K, a 105.08% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for the quarter ending 2024-12-31 was -$185.00K, a 117.26% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for the quarter ending 2024-09-30 was $1.67M, a 343.77% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for the quarter ending 2024-06-30 was $87.00K, a 95.96% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for fiscal 2024 was $1.89M, a 54.30% decline from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for fiscal 2023 was $4.14M, a 161.77% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV proceeds from noncontrolling interests for fiscal 2022 was $1.58M, a 72.87% increase from fiscal 2021.
| Period end | Proceeds from Noncontrolling Interests 3 month | Proceeds from Noncontrolling Interests 6 month | Proceeds from Noncontrolling Interests 9 month | Proceeds from Noncontrolling Interests 9 month as first filed | Proceeds from Noncontrolling Interests 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | ||||
| 2025-03-31 | $646.00K 10-Q · filed 2025-05-09 | $461.00K derived: sum of 2 quarters · filed 2026-02-27 | $2.13M derived: sum of 3 quarters · filed 2026-02-27 | $2.22M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-12-31 | -$185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.49M derived: sum of 2 quarters · filed 2026-02-27 | $1.57M derived: sum of 3 quarters · filed 2026-02-27 | $1.89M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.76M derived: sum of 2 quarters · filed 2024-11-08 | $2.08M 10-Q · filed 2024-11-08 | $3.15M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $402.00K 10-Q · filed 2024-08-14 | $1.47M derived: sum of 3 quarters · filed 2026-02-27 | $1.85M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $315.00K 10-Q · filed 2025-05-09 | $1.39M derived: sum of 2 quarters · filed 2026-02-27 | $1.76M derived: sum of 3 quarters · filed 2026-02-27 | $3.92M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.45M derived: sum of 2 quarters · filed 2026-02-27 | $3.60M derived: sum of 3 quarters · filed 2026-02-27 | $4.14M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.53M derived: sum of 2 quarters · filed 2024-11-08 | $3.06M 10-Q · filed 2024-11-08 | $3.06M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.69M 10-Q · filed 2024-08-14 | $2.69M derived: sum of 3 quarters · filed 2025-03-03 | $2.79M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $532.00K 10-Q · filed 2024-05-08 | $532.00K derived: sum of 2 quarters · filed 2025-03-03 | $636.00K derived: sum of 3 quarters · filed 2025-03-03 | $2.11M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $104.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.58M derived: sum of 3 quarters · filed 2025-03-03 | $1.58M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.58M derived: sum of 2 quarters · filed 2023-11-08 | $1.58M 10-Q · filed 2023-11-08 | $1.58M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.48M 10-Q · filed 2023-08-09 | $1.48M derived: sum of 3 quarters · filed 2024-02-29 | $2.39M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-05 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $914.00K derived: sum of 3 quarters · filed 2024-02-29 | $627.00K derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $914.00K derived: sum of 2 quarters · filed 2024-02-29 | $627.00K derived: sum of 3 quarters · filed 2024-02-29 | $914.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $914.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $627.00K derived: sum of 2 quarters · filed 2022-11-08 | $914.00K 10-Q · filed 2022-11-08 | $0.00 10-Q · filed 2021-11-09 | $528.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | -$386.00K derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $287.00K 10-Q · filed 2022-05-09 | -$99.00K derived: sum of 2 quarters · filed 2023-02-28 | $287.00K derived: sum of 3 quarters · filed 2023-02-28 | $287.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | |
| 2020-09-30 | $386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $386.00K derived: sum of 2 quarters · filed 2021-11-09 | $386.00K 10-Q · filed 2021-11-09 | $3.26M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | $2.87M derived: sum of 3 quarters · filed 2022-03-01 | -$8.73M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $2.87M derived: sum of 2 quarters · filed 2022-03-01 | -$8.73M derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$8.73M derived: sum of 2 quarters · filed 2022-03-01 | $2.87M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$11.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | $11.60M 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $11.60M 10-Q · filed 2020-08-07 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $138.00K 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $138.00K 10-Q · filed 2016-11-04 | |||
| 2016-06-30 | $138.00K 10-Q · filed 2016-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |